IRIS Accounts Production v24.3.2.46 SC478792 director 1.6.23 31.5.24 31.5.24 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC4787922023-05-31SC4787922024-05-31SC4787922023-06-012024-05-31SC4787922022-05-31SC4787922022-06-012023-05-31SC4787922023-05-31SC478792ns15:Scotland2023-06-012024-05-31SC478792ns14:PoundSterling2023-06-012024-05-31SC478792ns10:Director12023-06-012024-05-31SC478792ns10:PrivateLimitedCompanyLtd2023-06-012024-05-31SC478792ns10:SmallEntities2023-06-012024-05-31SC478792ns10:AuditExempt-NoAccountantsReport2023-06-012024-05-31SC478792ns10:SmallCompaniesRegimeForDirectorsReport2023-06-012024-05-31SC478792ns10:SmallCompaniesRegimeForAccounts2023-06-012024-05-31SC478792ns10:FullAccounts2023-06-012024-05-31SC478792ns10:OrdinaryShareClass12023-06-012024-05-31SC478792ns10:RegisteredOffice2023-06-012024-05-31SC478792ns5:CurrentFinancialInstruments2024-05-31SC478792ns5:CurrentFinancialInstruments2023-05-31SC478792ns5:Non-currentFinancialInstruments2024-05-31SC478792ns5:Non-currentFinancialInstruments2023-05-31SC478792ns5:ShareCapital2024-05-31SC478792ns5:ShareCapital2023-05-31SC478792ns5:RetainedEarningsAccumulatedLosses2024-05-31SC478792ns5:RetainedEarningsAccumulatedLosses2023-05-31SC478792ns5:PlantMachinery2023-06-012024-05-31SC478792ns5:ComputerEquipment2023-06-012024-05-31SC478792ns5:PlantMachinery2023-05-31SC478792ns5:ComputerEquipment2023-05-31SC478792ns5:PlantMachinery2024-05-31SC478792ns5:ComputerEquipment2024-05-31SC478792ns5:PlantMachinery2023-05-31SC478792ns5:ComputerEquipment2023-05-31SC478792ns5:WithinOneYearns5:CurrentFinancialInstruments2024-05-31SC478792ns5:WithinOneYearns5:CurrentFinancialInstruments2023-05-31SC478792ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2024-05-31SC478792ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2023-05-31SC478792ns10:OrdinaryShareClass12024-05-31SC478792ns5:RetainedEarningsAccumulatedLosses2023-05-31SC478792ns5:RetainedEarningsAccumulatedLosses2023-06-012024-05-31
REGISTERED NUMBER: SC478792 (Scotland)















Unaudited Financial Statements For The Year Ended 31 May 2024

for

Alvi Health Limited

Alvi Health Limited (Registered number: SC478792)






Contents of the Financial Statements
For The Year Ended 31 May 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Alvi Health Limited

Company Information
For The Year Ended 31 May 2024







DIRECTOR: B Alvi





REGISTERED OFFICE: 40 Heathcliff Drive
Eastkilbride
Glasgow
G75 8ZA





REGISTERED NUMBER: SC478792 (Scotland)





ACCOUNTANTS: Ahmad & Nabi Mcmullan
95-107 Lancefield Street
Glasgow
Lanarkshire
G3 8HZ

Alvi Health Limited (Registered number: SC478792)

Balance Sheet
31 May 2024

31.5.24 31.5.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,047 2,687

CURRENT ASSETS
Debtors 5 129,149 124,655
Cash at bank and in hand 28,348 46,433
157,497 171,088
CREDITORS
Amounts falling due within one year 6 9,525 10,823
NET CURRENT ASSETS 147,972 160,265
TOTAL ASSETS LESS CURRENT
LIABILITIES

150,019

162,952

CREDITORS
Amounts falling due after more than one
year

7

149,123

156,275
NET ASSETS 896 6,677

CAPITAL AND RESERVES
Called up share capital 9 100 100
Retained earnings 10 796 6,577
SHAREHOLDERS' FUNDS 896 6,677

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Alvi Health Limited (Registered number: SC478792)

Balance Sheet - continued
31 May 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 27 January 2025 and were signed by:





B Alvi - Director


Alvi Health Limited (Registered number: SC478792)

Notes to the Financial Statements
For The Year Ended 31 May 2024

1. STATUTORY INFORMATION

Alvi Health Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 20% on reducing balance
Computer equipment - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

Alvi Health Limited (Registered number: SC478792)

Notes to the Financial Statements - continued
For The Year Ended 31 May 2024

4. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1 June 2023
and 31 May 2024 4,822 5,490 10,312
DEPRECIATION
At 1 June 2023 4,178 3,447 7,625
Charge for year 129 511 640
At 31 May 2024 4,307 3,958 8,265
NET BOOK VALUE
At 31 May 2024 515 1,532 2,047
At 31 May 2023 644 2,043 2,687

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.5.24 31.5.23
£    £   
Trade debtors - 7,976
Other debtors 52,163 4,200
Victoria Road Studios Ltd 76,986 112,479
129,149 124,655

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.5.24 31.5.23
£    £   
Tax 8,556 8,699
Social security and other taxes 201 196
Directors' current accounts - 1,928
Accrued expenses 768 -
9,525 10,823

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.5.24 31.5.23
£    £   
Bank loans (see note 8) 141,665 145,505
BBL 7,458 10,770
149,123 156,275

Alvi Health Limited (Registered number: SC478792)

Notes to the Financial Statements - continued
For The Year Ended 31 May 2024

8. LOANS

An analysis of the maturity of loans is given below:

31.5.24 31.5.23
£    £   
Amounts falling due between one and two years:
Bank loans 141,665 145,505

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.5.24 31.5.23
value: £    £   
100 Ordinary 1 100 100

10. RESERVES
Retained
earnings
£   

At 1 June 2023 6,577
Profit for the year 35,219
Dividends (41,000 )
At 31 May 2024 796